Read + Share
Cui Y, Peng H. Imatinib and CAR T cell therapy enable sustained response in a young patient with
refractory RCSD1-ABL1-positive acute lymphoblastic leukemia. Ann Hematol 2023 Oct 21. doi: 10.1007/s00277-023-05489.
PMID: 37864715
|
 |
|
Cui Y, Peng H. Imatinib and CAR T cell therapy enable sustained response in a young patient with
refractory RCSD1-ABL1-positive acute lymphoblastic leukemia. Ann Hematol 2023 Oct 21. doi: 10.1007/s00277-023-05489.
PMID: 37864715
|
|
|
|